US 10653710
Combination therapy for treating malignancies
granted A61KA61K31/444A61K31/706
Quick answer
US patent 10653710 (Combination therapy for treating malignancies) held by Agios Pharmaceuticals, Inc. expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/444, A61K31/706, A61K45/06, A61P